Q1 2024 Urogen Pharma Ltd Earnings Call Transcript

May 13, 2024 / 02:00PM GMT
Operator

Good morning ladies and gentlemen. Thank you for standing by. Welcome to the UroGen Pharma first quarter 2024 earnings call. Please be advised that today's conference is being recorded. I'd now like to hand the conference over to your first speaker today, Vincent Perrone, Head of Investment Relations. You may begin.

Vincent Perrone - Urogen Pharma Ltd - Investor Relations

Thank you operator. Good morning, everyone and welcome to UroGen Pharma's first quarter 2024 financial results and business update conference call. Earlier this morning we issued a press release providing an overview of our corporate highlights and financial results for the quarter ended March 31, 2024. The press release can be accessed on the investors portion of our website.

Joining me today are Liz Barrett, President, and Chief Executive Officer; Dr. Mark Schoenberg, Chief Medical Officer; Jeff Bova, Chief Commercial Officer; and Dong Kim, Chief Financial Officer.

During today's call, we will be making certain forward-looking statements. These may include statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot